Phase 4
N=600
Patient Satisfaction With Propofol for Out Patient Colonoscopy
Colon Cancer · IBS · Polyps
Bottom Line
View on ClinicalTrials.gov: NCT02937506 ↗Enrolled (actual)
600
Serious AEs
0.0%
Results posted
Sep 2017
Primary outcome: Primary: Patient Satisfaction — 259; 222; 37; 66 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 4
- Interventions
- Propofol (Drug); Fentanyl Plus Midazolam (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mount Carmel Health System
- Primary completion
- Mar 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Patient Satisfaction |
259; 222; 37; 66; 4; 12 | — |
Summary
The primary purpose of this study is to determine if patient satisfaction with propofol is better than with non-propofol anesthesia for outpatient colonoscopies.
Eligibility Criteria
Inclusion Criteria
- Patients having an outpatient colonoscopy
Exclusion Criteria
- High risk patients (ASA IV & V) who are not candidates for colonoscopy in an outpatient center will be excluded.
Data sourced from ClinicalTrials.gov (NCT02937506). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.